About University Hospital coventry; Oncology Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Clinical Trials at University Hospital coventry; Oncology Department
During the past decade, University Hospital coventry; Oncology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
2012-02-17
2019-11-14
Completed
258
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
2012-11-27
2020-07-31
Completed
2,185
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer
2018-01-06
2023-01-04
Completed
580
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital coventry; Oncology Department"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at University Hospital coventry; Oncology Department
According to Clinical.Site data, the most researched conditions in "University Hospital coventry; Oncology Department" are
"Breast Cancer" (4 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "University Hospital coventry; Oncology Department" in a lesser frequency.
Clinical Trials Intervention Types at University Hospital coventry; Oncology Department
Most popular intervention types in "University Hospital coventry; Oncology Department" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (3 trials), "Docetaxel" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at University Hospital coventry; Oncology Department
The vast majority of trials in "University Hospital coventry; Oncology Department" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at University Hospital coventry; Oncology Department
Currently, there are NaN active trials in "University Hospital coventry; Oncology Department".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in University Hospital coventry; Oncology Department,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University Hospital coventry; Oncology Department, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".